- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Home > Press > ETPL celebrates a decade of bringing science to market, announces focus areas beyond 2012: Innovation Clusters, or Hotspots, to include Diagnostics, Anti-Microbials, Bio-imaging, Printed Electronics and Business Analytics
ETPL, the technology transfer arm of A*STAR, today announced it has earmarked five Innovation Clusters or Hotspots aimed at strengthening Singapore's research and business ecosystem.
Its goal: to drive a consistent pipeline of technologies for commercialisation as well as build clusters of industries around these Hotspots. Spanning both the Biomedical Science and Science & Engineering sectors, the focus areas are: Diagnostics, Anti-Microbials, Bio-imaging, Printed Electronics and Business Analytics.
These areas were selected based on market potential as well as the strength and leadership of A*STAR's research in those areas. Patent strength in technologies that support the Hotspots was also a factor, along with the speed at which each Hotspot is likely to mature, deliver results, and reach leadership position.
"Technology transfer isn't just about numbers and revenue," said ETPL CEO Philip Lim. "ETPL's role includes creating new jobs, transforming industry and giving Singapore businesses a competitive edge. The world beyond 2012 will rely increasingly on ecosystems of partnership for success. It is a world of collaborative business models in which marketing savvy and IP prowess go hand in hand. ETPL will continue to build on our results and partnerships to grow these ecosystems."
ETPL was set up in January 2002 to commercialise the outcomes of A*STAR's research institutes and to consolidate the research organisation's patent portfolio. Today, ETPL:
• Manages more than 3,500 active patents and applications
• Has granted more than 400 licences for A*STAR technologies - with expected revenues of more than $500 million
• Has spun off more than 40 start-ups
• Serves diverse industries including biotechnology, ICT, manufacturing, shipping, and more
In 2011 alone, ETPL achieved 40% of MTI's 5-year targets for licences as well as Realised Imputed Commercial Value, defined as the revenue the licensee is expected to generate from incorporating the technology. Its patent utilisation rate tripled year-on-year and it saw double-digit growth in the number of A*STAR start-ups.
ETPL is a one stop resource that bridges the gap between research and market. Its officers work extremely closely with their A*STAR counterparts to identify market opportunities and promising research as well as work with scientists and industry players to create licensing and spin-off opportunities.
ETPL identifies A*STAR technology that businesses can license and build into their products and/or improve processes. It also works within A*STAR and its ecosystem to build an environment for entrepreneurship to thrive as well as engage the community via outreach opportunities such as Distinguished Technopreneur Speaker Forum series, Industry Forums, public-private collaborations.
"Moving ahead, we will continue our focus on integrative industry engagement and look to becoming international in our outlook as well as commandeering industry leadership for all technology transfer services," said Philip.
ETPL is the commercialization arm of the Agency for Science, Technology and Research (A*STAR). Its mission is to support A*STAR in transforming the economy through commercializing R&D. Formerly referred to as Exploit Technologies, the organisation enhances the research output of A*STAR scientists by translating their inventions into marketable products or processes.
Through licensing deals and spin-offs with industry partners, ETPL is a key driver of technology transfer in Singapore. It actively engages industry leaders and players to commercialise A*STAR’s technologies and capabilities, bridging the gap from Mind to Market. ETPL’s charter is to identify, protect and exploit promising intellectual property (IP) created by A*STAR’s research institutes.
For more information, please click here
Phone: (65) 8157 8832
Phone: (65) 6478 8443
Copyright © ETPLIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Scientists 'see' detailed make-up of deadly toxin for the first time: Exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia November 25th, 2015
UCLA nanoscientists develop safer, faster way to remove pollutants from water November 23rd, 2015
Researchers find new phase of carbon, make diamond at room temperature November 30th, 2015
RAMAN Spectrometry Makes Characterization of Various Nanostructures Possible November 28th, 2015
Medical and aerospace electronics powered by Picosun ALD November 26th, 2015
Electric fields remove nanoparticles from blood with ease November 24th, 2015
Calling All Industries: Get Your Graphene By The Kiloton November 21st, 2015
Screen Printable Functionalised Graphene Ink November 3rd, 2015
Monolithic perovskite/silicon tandem solar cell achieves record efficiency October 30th, 2015
Crystal clear: Thousand-fold fluorescence enhancement in an all-polymer thin film: Griffith University researchers report breakthrough due to novel and multi-layer Colloidal Photonic Crystal structure October 2nd, 2015